AAPL 173.18 2.2918% MSFT 397.84 0.7343% GOOG 168.46 1.7455% GOOGL 166.62 1.6844% AMZN 184.72 3.1955% NVDA 858.11 3.3357% META 441.84 0.6034% TSLA 180.1 0.0611% TSM 136.23 0.956% LLY 755.91 -2.683% V 267.61 0.1085% AVGO 1238.3 -0.3669% JPM 191.66 -0.1042% UNH 492.97 1.8302% NVO 124.02 -4.0167% WMT 59.71 1.4613% LVMUY 164.94 0.5609% XOM 116.24 0.181% LVMHF 825.49 0.3843% MA 441.1 -0.2194%
Last update at 2024-05-02T20:00:00Z
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Income before tax | 721.00M | 830.55M | 499.89M | 680.31M | 695.35M |
| Minority interest | 28.00M | 29.29M | 15.63M | -24.77000M | 26.25M |
| Net income | 538.00M | 631.23M | 403.79M | 520.79M | 535.88M |
| Selling general administrative | 2771.00M | 2812.66M | 2246.95M | 2357.92M | 2217.27M |
| Selling and marketing expenses | - | - | - | - | - |
| Gross profit | 3831.00M | 3672.25M | 2814.34M | 3090.89M | 3595.08M |
| Reconciled depreciation | 212.00M | 209.53M | 185.54M | 184.94M | 207.56M |
| Ebit | 747.00M | 851.66M | 535.30M | 718.26M | 914.29M |
| Ebitda | 1108.00M | 1075.62M | 758.90M | 930.75M | 1121.85M |
| Depreciation and amortization | 361.00M | 223.96M | 223.60M | 212.49M | 207.56M |
| Non operating income net other | 33.00M | 33.82M | 19.89M | 217.51M | 43.35M |
| Operating income | 747.00M | 851.66M | 535.30M | 718.26M | 753.05M |
| Other operating expenses | 11769.00M | 11541.43M | 9551.75M | 9252.84M | 12308.79M |
| Interest expense | 44.00M | 27.60M | 41.38M | 50.79M | 78.79M |
| Tax provision | 170.00M | 197.35M | 95.37M | 159.51M | 155.49M |
| Interest income | 17.00M | 6.45M | 9.84M | 15.76M | 21.24M |
| Net interest income | -27.00000M | -21.14900M | -31.53500M | -35.03500M | -57.55000M |
| Extraordinary items | - | - | - | -5.95700M | 116.84M |
| Non recurring | - | 7.94M | 32.09M | 14.71M | 101.40M |
| Other items | - | - | - | - | - |
| Income tax expense | 170.00M | 197.35M | 95.37M | 159.51M | 155.49M |
| Total revenue | 12647.00M | 12401.02M | 10119.14M | 9985.80M | 13202.00M |
| Total operating expenses | 2953.00M | 2812.66M | 2246.95M | 2357.92M | 2701.88M |
| Cost of revenue | 8816.00M | 8728.77M | 7304.80M | 6894.92M | 9606.91M |
| Total other income expense net | -26.00000M | -21.10800M | -35.40800M | -37.95400M | -140.31000M |
| Discontinued operations | - | - | 0.99M | -6.32300M | 105.16M |
| Net income from continuing ops | 566.00M | 660.53M | 418.44M | 725.46M | 539.86M |
| Net income applicable to common shares | 538.00M | 631.23M | 403.79M | 694.73M | 535.88M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Total assets | 8607.00M | 8481.09M | 7772.53M | 7151.10M | 8500.53M |
| Intangible assets | 587.00M | 667.63M | 479.43M | 572.88M | 584.24M |
| Earning assets | - | - | - | - | - |
| Other current assets | 466.00M | 413.10M | 432.94M | 445.36M | 520.56M |
| Total liab | 3936.00M | 4417.90M | 3788.15M | 3520.96M | 4958.74M |
| Total stockholder equity | 3446.00M | 3425.13M | 3348.17M | 2998.04M | 2961.33M |
| Deferred long term liab | 36.00M | 42.28M | 30.07M | 64.99M | 31.57M |
| Other current liab | 1038.00M | 1115.02M | 1029.53M | 958.93M | 1031.20M |
| Common stock | 1.00M | 1.37M | 1.43M | 1.43M | 1.51M |
| Capital stock | 1.00M | 1.37M | 1.43M | 1.43M | 1.51M |
| Retained earnings | 3678.00M | 3595.23M | 3454.83M | 3116.22M | 3208.59M |
| Other liab | 397.00M | 418.95M | 422.85M | 396.16M | 447.41M |
| Good will | 2893.00M | 2854.15M | 2504.39M | 2462.49M | 2820.30M |
| Other assets | 232.00M | 190.41M | 149.41M | 120.81M | 1254.83M |
| Cash | 117.00M | 117.97M | 421.19M | 106.10M | 80.21M |
| Cash and equivalents | - | - | - | - | - |
| Total current liabilities | 2224.00M | 2306.51M | 2283.10M | 2038.37M | 3218.83M |
| Current deferred revenue | - | - | - | 64.99M | - |
| Net debt | 1380.00M | 1098.72M | 581.23M | 892.25M | 1884.08M |
| Short term debt | 182.00M | 137.56M | 247.92M | 199.17M | 960.41M |
| Short long term debt | 109.00M | 61.17M | 183.20M | 133.82M | 960.41M |
| Short long term debt total | 1497.00M | 1216.68M | 1002.42M | 998.35M | 1964.29M |
| Other stockholder equity | -233.00000M | 1.37M | 1054.31M | 47.77M | 1.51M |
| Property plant equipment | 667.00M | 366.46M | 342.00M | 329.64M | 382.40M |
| Total current assets | 3988.00M | 3844.03M | 3791.41M | 3226.50M | 4175.22M |
| Long term investments | 472.00M | 423.87M | 366.44M | 327.92M | 538.37M |
| Net tangible assets | 542.00M | 516.66M | 692.05M | 249.93M | -131.05100M |
| Short term investments | - | - | - | - | - |
| Net receivables | 1442.00M | 1451.83M | 1424.79M | 1246.25M | 1603.71M |
| Long term debt | 1040.00M | 811.35M | 515.77M | 622.91M | 1003.87M |
| Inventory | 1963.00M | 1861.14M | 1512.50M | 1428.80M | 1970.74M |
| Accounts payable | 1004.00M | 1053.93M | 1005.65M | 880.27M | 1227.21M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | 649.00M | 638.07M | 636.21M | 632.09M | 580.46M |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | -233.00000M | -171.47800M | -108.08400M | -167.37300M | -248.77100M |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | 1.00M | 1.37M | 1.43M | 1.43M | 1.51M |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | 3678.00M | 3595.23M | 3454.83M | 3116.22M | 3208.59M |
| Treasury stock | - | - | - | - | - |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | 223.00M | -34.60700M | 154.47M | -23.62500M | -83.24200M |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 4619.00M | 4637.06M | 3981.12M | 3924.60M | 4325.31M |
| Capital lease obligations | 348.00M | 344.17M | 303.44M | 241.62M | - |
| Long term debt total | 1040.00M | 811.35M | 515.77M | 622.91M | 1003.87M |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Investments | 11.00M | 5.67M | 12.78M | 323.96M | -24.70000M |
| Change to liabilities | -96.00000M | 84.71M | 224.27M | 160.85M | 241.65M |
| Total cashflows from investing activities | -276.00000M | -677.21700M | -115.01900M | -424.37300M | -192.95400M |
| Net borrowings | 259.00M | 161.43M | -68.99300M | -1188.50600M | 297.20M |
| Total cash from financing activities | -315.00000M | -332.95700M | -187.18500M | -215.98000M | -603.77600M |
| Change to operating activities | -52.00000M | 9.06M | -6.47900M | -57.29100M | -165.64500M |
| Net income | 566.00M | 660.53M | 419.42M | 719.14M | 562.13M |
| Change in cash | -1.00000M | -303.22000M | 315.09M | 49.21M | -94.44900M |
| Begin period cash flow | 118.00M | 421.19M | 106.10M | 56.88M | 174.66M |
| End period cash flow | 117.00M | 117.97M | 421.19M | 106.10M | 80.21M |
| Total cash from operating activities | 602.00M | 709.58M | 598.91M | 654.09M | 684.71M |
| Issuance of capital stock | - | 0.00000M | - | 361.09M | - |
| Depreciation | 212.00M | 209.53M | 185.54M | 184.94M | 207.56M |
| Other cashflows from investing activities | -191.00000M | -603.86900M | -78.96700M | -672.11800M | -77.61700M |
| Dividends paid | - | - | - | -148.14600M | 17.52M |
| Change to inventory | -126.00000M | -295.13100M | -31.81700M | 14.70M | -84.78400M |
| Change to account receivables | -7.00000M | 4.16M | -189.34900M | -72.68900M | -147.49900M |
| Sale purchase of stock | -485.00000M | -401.21100M | -73.78900M | -525.00000M | -200.00000M |
| Other cashflows from financing activities | 229.00M | 208.93M | 497.82M | 1284.93M | -375.73400M |
| Change to netincome | 93.00M | 38.67M | 23.19M | -303.83000M | 8.37M |
| Capital expenditures | 96.00M | 79.02M | 48.83M | 76.22M | 90.64M |
| Change receivables | -7.00000M | 4.16M | -189.34900M | -72.68900M | -147.49900M |
| Cash flows other operating | -40.00000M | 7.11M | 387.08M | 670.11M | -102.70900M |
| Exchange rate changes | - | - | - | - | 17.57M |
| Cash and cash equivalents changes | 11.00M | -300.59400M | 296.71M | 13.73M | -94.44900M |
| Change in working capital | -281.00000M | -197.20100M | -3.37200M | 45.57M | -82.69600M |
| Stock based compensation | 54.00M | 78.42M | 8.79M | 44.92M | 36.24M |
| Other non cash items | 112.00M | -28.75600M | 66.39M | -338.37000M | 13.34M |
| Free cash flow | 506.00M | 630.57M | 550.08M | 577.87M | 594.07M |
Sector: Healthcare Industry: Medical Distribution
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| HSIC Henry Schein Inc |
-0.18 0.26% | 68.60 | 21.82 | 14.33 | 0.76 | 2.63 | 0.92 | 12.98 |
| MCK McKesson Corporation |
-0.83 0.16% | 530.27 | 17.95 | 14.53 | 0.20 | 5.04 | 0.22 | 12.17 |
| COR Cencora Inc. |
-4.43 1.93% | 224.77 | 23.39 | - | - | - | ||
| CAH Cardinal Health Inc |
0.81 0.79% | 102.98 | 166.11 | 14.71 | 0.12 | 16.07 | 0.12 | 19.78 |
| SHPMF Shanghai Pharmaceuticals Holding Co. Ltd |
- -% | 1.21 | 7.71 | 5.45 | 0.03 | 0.57 | 0.03 | 0.88 |
Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners. This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners, and consulting and other services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
135 Duryea Road, Melville, NY, United States, 11747
| Name | Title | Year Born |
|---|---|---|
| Mr. Stanley M. Bergman | Exec. Chairman & CEO | 1950 |
| Mr. James P. Breslawski | Exec. Vice Chairman & Pres | 1954 |
| Mr. Steven Paladino | Exec. Director | 1957 |
| Mr. Mark E. Mlotek | Exec. VP, Chief Strategic Officer & Exec. Director | 1956 |
| Mr. Ronald N. South | Sr. VP & CFO | 1962 |
| Mr. Michael Saul Ettinger | Exec. VP & COO | 1961 |
| Ms. Olga Timoshkina | VP of Corp. Fin., Chief Accounting Officer & Corp. Controller | NA |
| Mr. Christopher Pendergast | Sr. VP & CTO | 1964 |
| Graham Stanley | VP of Investor Relations & Strategic Fin. Project Officer | NA |
| Mr. Walter Siegel | Sr. VP & Chief Legal Officer | 1960 |
Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).
US 
AU
UK
CA
NZ
Please wait processing your request...